24 Jul Psilocybin for anorexia shows promise in early trial
10-woman study found the psychoactive compound to be safe, positively perceived....
10-woman study found the psychoactive compound to be safe, positively perceived....
The agency proposes significant revisions to oversight programs for drugs and medical products....
Clinical research must be inclusive of all body types and identities....
A researcher weighs in on the current state of decentralized clinical trials, their potential to increase participant diversity, and what research is still needed to confirm their efficacy....
The COVID pandemic knocked back progress towards improving public health. Without addressing the underlying social and economic causes of ill health, it could completely stall....
More restrictive LGBTQ+ bills are being passed in the US that might negatively impact transgender individuals in clinical trials....
UW Health is recruiting volunteers for a clinical trial to test a new Alzheimer's drug recently approved by the FDA....
The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease....
The FDA is expected to approve the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, some critics predict the rollout of the drug will aggravate racial disparities in elder care....
The first drug fully generated by artificial intelligence entered clinical trials with human patients this week. The drug was created as a treatment for idiopathic pulmonary fibrosis, a chronic lung disease....